Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High‐Risk Recurrence Factors: A Phase II Single‐Center Prospective Study.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High‐Risk Recurrence Factors: A Phase II Single‐Center Prospective Study.
Authors: Tian, Yitong1,2 (AUTHOR), Lei, Tian1 (AUTHOR), Ruan, Qingyang3 (AUTHOR), Zhou, Xueying1,2 (AUTHOR), Shen, Ruijing1,2 (AUTHOR), Xie, Tianao1,2 (AUTHOR), Li, Shijie1,2 (AUTHOR), Cai, Xiujun1,2 (AUTHOR) srrsh_cxj@zju.edu.cn, Chen, Mingyu1,2 (AUTHOR) mychen@zju.edu.cn
Source: Cancer Medicine. Apr2026, Vol. 15 Issue 4, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 193257950
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High‐Risk Recurrence Factors: A Phase II Single‐Center Prospective Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Tian%2C+Yitong%22">Tian, Yitong</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lei%2C+Tian%22">Lei, Tian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ruan%2C+Qingyang%22">Ruan, Qingyang</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Xueying%22">Zhou, Xueying</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+Ruijing%22">Shen, Ruijing</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+Tianao%22">Xie, Tianao</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Shijie%22">Li, Shijie</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cai%2C+Xiujun%22">Cai, Xiujun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> srrsh_cxj@zju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Chen%2C+Mingyu%22">Chen, Mingyu</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> mychen@zju.edu.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Apr2026, Vol. 15 Issue 4, p1-11. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193257950
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cam4.71756
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 1
    Titles:
      – TitleFull: Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High‐Risk Recurrence Factors: A Phase II Single‐Center Prospective Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tian, Yitong
      – PersonEntity:
          Name:
            NameFull: Lei, Tian
      – PersonEntity:
          Name:
            NameFull: Ruan, Qingyang
      – PersonEntity:
          Name:
            NameFull: Zhou, Xueying
      – PersonEntity:
          Name:
            NameFull: Shen, Ruijing
      – PersonEntity:
          Name:
            NameFull: Xie, Tianao
      – PersonEntity:
          Name:
            NameFull: Li, Shijie
      – PersonEntity:
          Name:
            NameFull: Cai, Xiujun
      – PersonEntity:
          Name:
            NameFull: Chen, Mingyu
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 04
              Text: Apr2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 20457634
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cancer Medicine
              Type: main
ResultId 1